Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTM-001 for Moderately Severe Postoperative Pain Following Bunionectomy
NCT05324358Phase 3Suspended
- Start
- Dec 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketorolac in postoperative pain (3 arms). Primary endpoint: Summed Pain Intensity Difference at 24 hours. Started Dec 2022; status: suspended.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05324358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05324358.